These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 14532794

  • 1. Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age.
    Critz FA, Williams WH, Levinson AK, Benton JB, Schnell FJ, Holladay CT, Shrake PD.
    J Urol; 2003 Nov; 170(5):1864-7. PubMed ID: 14532794
    [Abstract] [Full Text] [Related]

  • 2. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer.
    Critz FA, Williams WH, Benton JB, Levinson AK, Holladay CT, Holladay DA.
    J Urol; 2000 Apr; 163(4):1085-9. PubMed ID: 10737471
    [Abstract] [Full Text] [Related]

  • 3. Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.
    Mitchell DM, Swindell R, Elliott T, Wylie JP, Taylor CM, Logue JP.
    Radiother Oncol; 2008 Jul; 88(1):102-7. PubMed ID: 18453022
    [Abstract] [Full Text] [Related]

  • 4. PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone.
    Akyol F, Ozyigit G, Selek U, Karabulut E.
    Eur Urol; 2005 Jul; 48(1):40-5. PubMed ID: 15967250
    [Abstract] [Full Text] [Related]

  • 5. A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL Is clinically significant after external beam radiotherapy for prostate cancer.
    Feigenberg SJ, Hanlon AL, Horwitz EM, Uzzo RG, Eisenberg D, Pollack A.
    Am J Clin Oncol; 2006 Oct; 29(5):458-62. PubMed ID: 17023779
    [Abstract] [Full Text] [Related]

  • 6. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.
    Zelefsky MJ, Marion C, Fuks Z, Leibel SA.
    J Urol; 2003 Nov; 170(5):1828-32. PubMed ID: 14532785
    [Abstract] [Full Text] [Related]

  • 7. Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis.
    Satoh T, Ishiyama H, Matsumoto K, Tsumura H, Kitano M, Hayakawa K, Ebara S, Nasu Y, Kumon H, Kanazawa S, Miki K, Egawa S, Aoki M, Toya K, Yorozu A, Nagata H, Saito S, Baba S.
    BJU Int; 2009 Apr; 103(8):1064-8. PubMed ID: 19040526
    [Abstract] [Full Text] [Related]

  • 8. PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.
    Ciezki JP, Reddy CA, Garcia J, Angermeier K, Ulchaker J, Mahadevan A, Chehade N, Altman A, Klein EA.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):512-7. PubMed ID: 16213667
    [Abstract] [Full Text] [Related]

  • 9. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
    Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A, Kuban D.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):795-9. PubMed ID: 15925452
    [Abstract] [Full Text] [Related]

  • 10. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P, Kuban D, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):415-9. PubMed ID: 15667961
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy.
    Crook J, Gillan C, Yeung I, Austen L, McLean M, Lockwood G.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):426-33. PubMed ID: 17869662
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen Z, Lief JH, Adamovich E.
    Urology; 2005 Jan 01; 65(1):95-100. PubMed ID: 15667872
    [Abstract] [Full Text] [Related]

  • 15. [PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure].
    Toledano A, Chauveinc L, Flam T, Thiounn N, Solignac S, Timbert M, Rosenwald JC, Cosset JM.
    Cancer Radiother; 2007 May 01; 11(3):105-10. PubMed ID: 17158082
    [Abstract] [Full Text] [Related]

  • 16. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation.
    Rosser CJ, Chichakli R, Levy LB, Kuban DA, Smith LG, Pisters LL.
    J Urol; 2002 Aug 01; 168(2):536-41. PubMed ID: 12131304
    [Abstract] [Full Text] [Related]

  • 17. Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis.
    Horwitz EM, Levy LB, Thames HD, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL, Kuban DA.
    Cancer; 2006 Oct 01; 107(7):1496-502. PubMed ID: 16944536
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous radiotherapy for prostate cancer: 125I prostate implant followed by external-beam radiation.
    Critz FA, Levinson AK, Williams WH, Holladay CT, Griffin VD, Holladay DA.
    Cancer J Sci Am; 1998 Oct 01; 4(6):359-63. PubMed ID: 9853134
    [Abstract] [Full Text] [Related]

  • 19. Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancer.
    Sheinbein C, Teh BS, Mai WY, Grant W, Paulino A, Butler EB.
    Urology; 2010 Sep 01; 76(3):728-33. PubMed ID: 19616279
    [Abstract] [Full Text] [Related]

  • 20. Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer.
    Burri RJ, Ho AY, Forsythe K, Cesaretti JA, Stone NN, Stock RG.
    Int J Radiat Oncol Biol Phys; 2010 Aug 01; 77(5):1315-21. PubMed ID: 20044216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.